Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Drug Discov Devel. 2004 Jul;7(4):396-403.

    Virtual screening in lead discovery and optimization.

    Source

    University of California, San Francisco, Cancer Research Institute and Comprehensive Cancer Center, Box 0128, San Francisco, CA 94143-0128, USA. ajain@cc.ucsf.edu

    Abstract

    Virtual screening by molecular docking, using a protein with an experimentally determined structure as a target, has become an established method for lead discovery and for enhancing efficiency in lead optimization. Generalizations of the quantitative structure-activity relationship concept have led to approaches for virtual screening in the absence of a protein target structure, instead relying upon ligand-based models as surrogates of protein active sites. Recently reported methods for ligand-based virtual screening can achieve similar enrichment rates to those obtained using molecular docking. This review will discuss recent advances in both domains of virtual screening, including theoretical and practical advances and the implications for their application.

    PMID:
    15338948
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk